Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Davis

Showing results (251-260 of 437) with videos related to

Pageof 44
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 19, 2019
Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysisStefan Leucht, Anna Chaimani, Dimitris Mavridis, et al.
Clinical Rheumatology|December 19, 2016
Cardiovascular risk assessment in patients with rheumatoid arthritis: a correlative study of noninvasive arterial health testingErin M Scanlon, Rekha Mankad, Cynthia S Crowson, et al.
The Journal of Clinical Psychiatry|October 10, 2009
Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month studyRobert C Smith, Jean-Pierre Lindenmayer, John M Davis, et al.
Methods (San Diego, Calif.)|December 3, 2014
Aggregator: a machine learning approach to identifying MEDLINE articles that derive from the same underlying clinical trialWeixiang Shao, Clive E Adams, Aaron M Cohen, et al.
The Lancet. Psychiatry|March 20, 2025
The trajectory of sedative adverse events caused by antipsychotics: a meta-analysis of individual participant data from randomised, placebo-controlled, clinical trials in acute phase schizophreniaNobuyuki Nomura, Spyridon Siafis, Johannes Schneider-Thoma, et al.
Fungal Biology|December 3, 2014
Phylogeny of ambrosia beetle symbionts in the genus RaffaeleaTyler J Dreaden, John M Davis, Z Wilhelm de Beer, et al.
Psychological Medicine|October 19, 2019
Antipsychotic drugs <i>v.</i> barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysisSpyridon Siafis, Giacomo Deste, Anna Ceraso, et al.
Eclinicalmedicine|April 9, 2026
Antipsychotic dose and efficacy for acute schizophrenia spectrum disorders: an updated systematic review and dose-response meta-analysisYuki Furukawa, Xiao Lin, Alessandro Rodolico, et al.
The Journal of Rheumatology|March 15, 2023
Trends in Incidence of Chronic Heart Failure in Patients With Rheumatoid Arthritis: A Population-Based Study Validating Different Heart Failure DefinitionsElena Myasoedova, Reto D Kurmann, Sara J Achenbach, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 9, 2023
Long-term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network meta-analysisStefan Leucht, Johannes Schneider-Thoma, Angelika Burschinski, et al.
Pageof 44

Showing results (251-260 of 437) with videos related to

Sort By:
Pageof 44
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 19, 2019
Disconnection of drug-response and placebo-response in acute-phase antipsychotic drug trials on schizophrenia? Meta-regression analysisStefan Leucht, Anna Chaimani, Dimitris Mavridis, et al.
Clinical Rheumatology|December 19, 2016
Cardiovascular risk assessment in patients with rheumatoid arthritis: a correlative study of noninvasive arterial health testingErin M Scanlon, Rekha Mankad, Cynthia S Crowson, et al.
The Journal of Clinical Psychiatry|October 10, 2009
Effects of olanzapine and risperidone on glucose metabolism and insulin sensitivity in chronic schizophrenic patients with long-term antipsychotic treatment: a randomized 5-month studyRobert C Smith, Jean-Pierre Lindenmayer, John M Davis, et al.
Methods (San Diego, Calif.)|December 3, 2014
Aggregator: a machine learning approach to identifying MEDLINE articles that derive from the same underlying clinical trialWeixiang Shao, Clive E Adams, Aaron M Cohen, et al.
The Lancet. Psychiatry|March 20, 2025
The trajectory of sedative adverse events caused by antipsychotics: a meta-analysis of individual participant data from randomised, placebo-controlled, clinical trials in acute phase schizophreniaNobuyuki Nomura, Spyridon Siafis, Johannes Schneider-Thoma, et al.
Fungal Biology|December 3, 2014
Phylogeny of ambrosia beetle symbionts in the genus RaffaeleaTyler J Dreaden, John M Davis, Z Wilhelm de Beer, et al.
Psychological Medicine|October 19, 2019
Antipsychotic drugs <i>v.</i> barbiturates or benzodiazepines used as active placebos for schizophrenia: a systematic review and meta-analysisSpyridon Siafis, Giacomo Deste, Anna Ceraso, et al.
Eclinicalmedicine|April 9, 2026
Antipsychotic dose and efficacy for acute schizophrenia spectrum disorders: an updated systematic review and dose-response meta-analysisYuki Furukawa, Xiao Lin, Alessandro Rodolico, et al.
The Journal of Rheumatology|March 15, 2023
Trends in Incidence of Chronic Heart Failure in Patients With Rheumatoid Arthritis: A Population-Based Study Validating Different Heart Failure DefinitionsElena Myasoedova, Reto D Kurmann, Sara J Achenbach, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 9, 2023
Long-term efficacy of antipsychotic drugs in initially acutely ill adults with schizophrenia: systematic review and network meta-analysisStefan Leucht, Johannes Schneider-Thoma, Angelika Burschinski, et al.
Pageof 44